Eli Lilly drug shown to slow Alzheimer’s progression

Eli Lilly drug shown to slow Alzheimer’s progression

Dementia experts hail ‘watershed moment’ after trial results for donanemab antibody treatment

Leave a Reply

Your email address will not be published. Required fields are marked *

Page Reader Press Enter to Read Page Content Out Loud Press Enter to Pause or Restart Reading Page Content Out Loud Press Enter to Stop Reading Page Content Out Loud Screen Reader Support
WordPress Cookie Plugin by Real Cookie Banner